SARS-CoV-IN-4

SARS-CoV-IN-4

• CAS Number: 2445585-37-3
• UNSPSC Description: SARS-CoV-IN-4 (compound 13) is a potent and specific inhibitor of SARS-CoV nsp14 N7-methyltransferase, with an IC50 of 0.6 μM (SARS-CoV nsp14)[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-in-4.html
• Solubility: 10 mM in DMSO
• Smiles: O[C@H]([C@@H]1O)[C@@](N2C3=NC=NC(N)=C3N=C2)([H])O[C@@H]1CN(S(=O)(C4=CC([N+]([O-])=O)=C(C=C4)Cl)=O)CCO[C@H]5[C@](O[C@@H]([C@H]5O)CO)([H])N6C7=NC=NC(N)=C7N=C6
• Molecular Weight: 779.14
• References & Citations: [1]Ahmed-Belkacem R, et al. Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase. Eur J Med Chem. 2020 Sep 1;201:112557.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported